MINERVA NEUROSCIENCES INC (NERV)
US6033802058 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 34.82M | 40.91M | 36.10M | 60.80M | 25.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 802.55K | 1.09M | 4.00M | 1.40M | 2.10M | |||
| Total Current Assets | 35.62M | 42.00M | 40.20M | 62.20M | 27.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.52K | 10.88K | 0.00 | 0.00 | 100.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 14.87M | 14.87M | 14.90M | 14.90M | 14.90M | |||
| Intangibles | 10.64K | 17.03K | 0.00 | 100.00K | 15.20M | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Total Non-Current Assets | 14.89M | 14.90M | 14.90M | 14.90M | 30.20M | |||
| TOTAL ASSETS | 50.51M | 56.90M | 55.10M | 77.10M | 57.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.40M | 1.54M | 400.00K | 1.00M | 2.20M | |||
| Accounts Payable | 1.44M | 1.81M | 1.00M | 1.90M | 1.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 2.83M | 3.34M | 1.40M | 2.80M | 3.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 1.80M | |||
| Other Non-Current Liabilities | 84.27M | 82.02M | 73.70M | 66.30M | 0.00 | |||
| Total Non-Current Liabilities | 84.27M | 82.02M | 73.70M | 66.30M | 1.80M | |||
| TOTAL LIABILITIES | 87.10M | 85.36M | 75.10M | 69.10M | 5.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -405.38M | -396.82M | -366.80M | -334.70M | -284.80M | |||
| Additional Paid In Capital | 368.80M | 368.36M | 346.80M | 342.70M | 337.50M | |||
| Common Shares | 700.00 | 700.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 6.99M | 6.99M | 5.30M | 5.30M | 5.30M | |||
| Tangible Book Value per Share | -7.36 | -6.20 | -6.58 | -1.32 | 4.26 | |||
| Total Shareholders' Equity | -36.59M | -28.46M | -20.00M | 8.00M | 52.70M | |||
| TOTAL LIABILITIES AND EQUITY | 50.51M | 56.90M | 55.10M | 77.10M | 57.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 12.58 | 12.57 | 28.71 | 22.21 | 8.56 | |||
| Return On Assets (ROA) | -62.56% | -52.73% | -58.28% | -64.73% | 3.37% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -623.88% | 3.68% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 2.69% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 5.04% | |||
All data in USD